Table of contents
In this update from Nguyen Injury Lawyer, we will cover:
- The current status of the Roundup class action lawsuit as of February 2026.
- The anticipated future direction of the Roundup litigation.
- Projected settlement amounts in the second phase of the Bayer Roundup lawsuit.
65,000 Roundup Cases and Counting
As of March 2026, Monsanto has reached settlement agreements in nearly 100,000 Roundup lawsuits, totaling approximately $11 billion. Bayer achieved this milestone through large-scale settlements with law firms handling numerous claims, as well as pre-trial resolutions in individual cases.
Despite these settlements, which account for roughly two-thirds of the total claims, Monsanto estimates that approximately 61,000 active Roundup lawsuits remain pending. The majority of these cases are now being litigated in state courts across the country, although over 4,000 remain consolidated in the federal MDL in California.
New lawsuits related to weedkiller exposure continue to be filed regularly. Our legal team at Nguyen Injury Lawyer is contacted daily by individuals newly diagnosed with non-Hodgkin lymphoma (NHL) after years of Roundup use. If you believe you may have a claim, please contact us through our online form or call XXX-XXX-XXXX.
Roundup Lawsuit News and Updates
The journey for victims of Roundup exposure has been lengthy and often frustrating. What began seven years ago with a single California jury awarding $289 million has evolved into one of the most significant product liability lawsuits in U.S. history. Bayer has been actively working to manage the fallout, fighting thousands of cases in court, securing multi-billion-dollar settlements, and developing legal strategies to protect itself from future claims.
Here’s a detailed timeline of verdicts, appeals, and legal developments:
March 24, 2026 – Roundup Settlements
There are increasing indications that more law firms involved in the Roundup litigation are agreeing to the proposed $7.25 billion settlement, which would resolve current and future non-Hodgkin lymphoma claims against Bayer.
March 11, 2026 – Roundup Settlements
Bayer suggests that it may finally be approaching the end of the long-standing Roundup cancer litigation, which has involved over a decade of lawsuits and more than 100,000 resolved claims. This assessment may be accurate.
Bayer is presenting a proposed $7.25 billion settlement and a U.S. Supreme Court appeal as potential turning points in the Roundup cancer litigation. While the settlement could provide resolution, the legal questions involved have been extensively examined and largely rejected.
Nguyen Injury Lawyer believes that closure for these victims would be beneficial, as it has been a long time coming for many.
March 5, 2026 – Roundup Settlements
A Missouri judge has granted preliminary approval to Bayer’s proposed $7.25 billion Roundup settlement, which the company hopes will resolve thousands of cancer claims linked to the weedkiller. The settlement aims to address both existing and future claims from individuals who allege that long-term exposure to Roundup’s active ingredient, glyphosate, caused non-Hodgkin lymphoma.
Under the proposal, class members will have until June 4, 2026, to opt out if they wish to pursue their own lawsuits. The settlement would be funded over a period of up to 21 years, as part of Bayer’s ongoing efforts to manage litigation that has plagued the company since its acquisition of Monsanto in 2018. Bayer has already spent over $10 billion resolving Roundup cases, and approximately 65,000 claims are still pending.
The parties are also awaiting a U.S. Supreme Court decision that will impact the future of Roundup lawsuits. The Court has agreed to hear Bayer’s appeal of a $1.25 million verdict, focusing on whether federal pesticide law preempts state law claims that Roundup should have carried stronger cancer warnings. Arguments are scheduled for April, with a decision expected later this year. Nguyen Injury Lawyer believes that Bayer’s substantial settlement offer indicates a likely anticipation of losing the appeal.
In the meantime, Bayer is heavily relying on this settlement to stabilize the litigation. However, the agreement is contingent on near-universal participation from plaintiffs, and Bayer reserves the right to withdraw if too many people opt out. While complete participation is unrealistic, strong participation numbers are crucial for the settlement to proceed.
March 2, 2026 – Roundup Settlements
Monsanto is attempting to settle these cases on a large scale through the Missouri state court system, while also settling cases outside of this framework.
February 23, 2026 – The MDL Might Get Moving Again
In an amended suggestion of remand filed in the Northern District of California, U.S. District Judge Vince Chhabria stated that several cases are ready for trial after discovery closed and Monsanto’s summary judgment motion was denied. These cases are part of Wave 7 of the MDL and did not settle following the court’s pretrial rulings, unlike many other cases in prior waves. These cases are presumably also eligible to participate in Monsanto’s settlement offer if they choose to do so.
February 19, 2026 – Trump Inserts Himself in Glyphosate Issue
Former President Trump signed an executive order invoking the Defense Production Act to classify glyphosate-based herbicides and elemental phosphorus as critical to national defense. The order directs the USDA, in collaboration with the Department of Defense, to prioritize domestic supply and potentially manage production and distribution.
The order extends beyond supply chain management, aiming to protect domestic producers that comply with federal directives by granting legal immunity. It instructs the USDA to prevent rules and regulatory pressure from threatening the corporate viability of companies producing these chemicals. Essentially, the government is treating glyphosate and phosphorus as essential war materials and seeking to ensure that domestic producers can continue operating without facing lawsuits or regulations.
The implications of this order are unclear.
February 18, 2026 – Settlement Problems
Wall Street’s initial positive reaction to Bayer’s settlement offer quickly turned negative upon closer examination. Similarly, while the deal initially appeared promising, a more detailed review reveals potential issues.
The proposed deal, designed to span 21 years and resolve thousands of non-Hodgkin lymphoma claims, may not be as beneficial as initially perceived. It requires court approval in Missouri, depends on near-universal claimant participation, and allows Bayer to withdraw if too many people opt out. There are also unconfirmed reports suggesting that the settlement is unreasonable for residential users of Roundup.
February 17, 2026 – Settlement Offer
Bayer is proposing a $7.25 billion class settlement to resolve both existing and future non-Hodgkin lymphoma claims over a 21-year period.
Additionally, the company has reportedly reached at least $3 billion in separate settlements of pending cases, including the resolution of a $2.1 billion Georgia verdict.
Bayer has already paid more than $10 billion in prior verdicts and settlements and still faces roughly 67,000 active claims. The proposed class deal would allow future claimants to submit claims for compensation but gives Monsanto the right to withdraw if too many people opt out. The agreement still requires court approval.
The settlement push comes as the United States Supreme Court prepares to hear Bayer’s preemption appeal in a Missouri case involving failure to warn claims. Bayer argues that federal EPA labeling decisions should block state law warning claims, an argument that, if successful, could significantly limit future trials. At the same time, Bayer has increased its litigation reserves to nearly €11.8 billion and secured an $8 billion loan facility to fund payouts, acknowledging the enormous financial strain of the litigation. Investors reacted positively to the settlement news, though some remain skeptical that the deal will prevent renewed waves of lawsuits if compensation offers are not strong enough to discourage opt-outs.
February 16, 2026 – Where Are We Now?
As of 2026, settlement discussions continue, driven by Bayer investors’ desire for a resolution. However, progress may slow down as the Supreme Court addresses the preemption issue. For many victims, this delay represents a denial of justice.
January 17, 2026 – Supreme Court
The U.S. Supreme Court has agreed to hear a case that could have significant implications for Bayer’s long-running Roundup litigation.
The review will address whether federal pesticide labeling rules preempt state failure-to-warn claims, an issue that has divided lower courts and fueled years of costly lawsuits.
While Bayer has welcomed the decision as an important step toward containing the litigation, the broader reality remains unchanged. With more than $10 billion already paid and tens of thousands of cases still open, this review may help bring clarity, but it is far from certain that it will be enough to alter Bayer’s overall exposure.
January 6, 2026 – Over 5,000 total cases
The Roundup MDL in the Northern District of California has 4,511 pending cases, with 5,240 total cases, as of January 2026.
December 9, 2025 – MDL Drops 18 Cases
The number of pending cases in the Roundup MDL in the Northern District of California decreased by 18 over the last month, bringing the total number of cases down to 4,508.
November 4, 2025 – 18 New Cases in MDL
Another 18 new cases were added to the Roundup MDL during the month of October, bringing the total number of pending cases in the MDL up to 4,490.
October 2, 2025 – Roundup MDL
Although the Roundup MDL is no longer frequently discussed, it remains the ninth-largest MDL in the country, with 4,472 cases still pending.
A recent order highlights why more cases are being filed in state court. The MDL judge ruled on the admissibility of several expert witnesses in the Roundup litigation, emphasizing that Rule 26 reports must stand on their own and that depositions cannot fill in the gaps.
As a result, some experts were excluded due to insufficient analysis, while others were deemed admissible.
September 20, 2025 – Monsanto Win Affirmed
The Illinois Appellate Court affirmed Monsanto’s trial win in a Cook County Roundup case, rejecting plaintiffs’ efforts to overturn a September 2023 defense verdict. The plaintiffs argued that the trial was tainted by juror bias, faulty jury instructions on proximate cause, and the trial court’s refusal to grant a continuance when their lead lawyers contracted COVID-19.
The panel held that the juror in question expressed frustration with plaintiffs’ counsel but ultimately affirmed his impartiality, and the trial judge acted within his discretion in keeping him. The court acknowledged that a more detailed proximate cause instruction might have been preferable, but found the short-form version adequate, given that there was only one defendant. It also upheld the denial of a mistrial after the plaintiffs’ counsel fell ill, noting that the trial was nearly complete and further delay would have placed an undue burden on the jurors.
These issues are challenging to win on appeal, as appellate courts typically defer to the trial judge’s decisions, often affirming rulings that the appellate judges would not have made themselves.
September 17, 2025 – Roundup Appeal: Monsanto Faces Stiff Task To Keep Win At 9th Cir.
If you or a loved one has been diagnosed with non-Hodgkin lymphoma after exposure to Roundup, contact Nguyen Injury Lawyer at XXX-XXX-XXXX for a free consultation. You can also reach us through our website.
A panel of the Ninth Circuit Court of Appeals recently heard arguments regarding a trial court’s decision to exclude a general-causation expert and subsequently dismiss a Roundup injury lawsuit via summary judgment.
The case originated from the Northern District of California’s Roundup MDL after the court deemed a peer-reviewed methodology inadmissible, leading to a judgment favoring the company. During the arguments, the appellate judges questioned both sides on the Daubert standard for admitting expert testimony and the extent of a trial court’s latitude in rejecting unreliable scientific evidence, while also acknowledging the extensive history and record of the MDL.
We are awaiting the ruling. Currently, there isn’t significant focus on the Roundup MDL.
September 2, 2025 – Bayer’s Roundup Replacement
It appears Bayer may be learning from its difficult experiences with Roundup. The company has announced that it has applied for regulatory approval for a new herbicide, CropKey, in the United States, the European Union, Brazil, and Canada. Unlike Roundup, which uses glyphosate as its active ingredient, CropKey relies on icafolin-methyl. Bayer is promoting it as a safer, next-generation product designed to avoid the cancer controversies that have plagued Roundup.
Bayer and its Monsanto subsidiary continue to face thousands of Roundup lawsuits, with new cases being filed regularly. Their efforts to limit liability through state law modifications have yielded inconsistent results. Juries continue to deliver substantial verdicts, and the scientific evidence linking long-term glyphosate exposure to cancer has become increasingly compelling. Given this context, Bayer hopes CropKey will not only start a new commercial chapter but also help resolve their litigation issues.
Bayer may be finally reducing the ongoing litigation. They have quietly settled thousands of Roundup cases this year and are now resolving the extensive PCB litigation. Recently, Bayer reached agreements in principle with over 200 plaintiffs who claimed PCB exposure at Sky Valley Education Center near Seattle. The stock market reacted positively to the settlement, suggesting it would welcome further Roundup settlements.
August 7, 2025 – Bayer Allocates Additional Funds for Roundup Settlements and Verdicts
Bayer’s latest financial report reveals an additional $1.37 billion allocated to its litigation reserves for Roundup, the widely debated weed killer involved in numerous cancer-related lawsuits in the U.S. The report also indicates settlements in thousands of lawsuits.
Is this sufficient? Not really. Is it a positive development? Absolutely.
Plaintiffs’ Roundup law firms generally have two approaches: (1) pursue a settlement similar to recent agreements, or (2) consider the settlement amounts inadequate and prepare to aggressively litigate more cases.
August 4, 2025 – Delaware Emerges as Another State Court Hub
Delaware state courts are becoming an increasingly popular venue for Roundup cancer lawsuits. A recent lawsuit filed in the Superior Court of Delaware includes 92 plaintiffs from across the nation who allege they developed Non-Hodgkin Lymphoma due to prolonged exposure to Roundup.
July 21, 2025 – Pesticide Injury Accountability Act
Over the past several years, a concerning trend has arisen in state legislatures, potentially weakening the rights of individuals harmed by toxic pesticides like Roundup. States such as Iowa and Idaho have passed laws that effectively shield pesticide manufacturers from liability if the EPA approves their products. These laws treat federal registration not just as a regulatory approval, but as a legal barrier against failure to warn claims. Consequently, victims of herbicide-related illnesses, including non-Hodgkin’s lymphoma, are denied justice in their state courts simply because the product received federal agency approval.
Senator Cory Booker has introduced the Pesticide Injury Accountability Act to address this issue. The proposed legislation aims to eliminate these state-level protections by amending FIFRA to establish a federal right of action for those injured by pesticides. This bill directly challenges Monsanto’s long-standing strategy of avoiding jury trials whenever possible.
June 30, 2025 – Supreme Court Seeks Input from Trump Administration
The U.S. Supreme Court has requested the Department of Justice’s opinion on Bayer’s latest effort to limit the thousands of lawsuits alleging its Roundup weed killer causes cancer. Bayer is appealing a Missouri court decision that upheld a $1.25 million jury verdict for a man who claimed his non-Hodgkin lymphoma was caused by long-term Roundup exposure. Bayer hopes the Supreme Court will determine that federal law, specifically the EPA’s approval of Roundup without a cancer warning, preempts state-law failure-to-warn claims.
Bayer’s CEO has expressed optimism. However, the stock market seems to disagree, with Bayer stock declining by 4.5% today.
June 24, 2025 – New Jersey Supreme Court Approves Multicounty Litigation for Roundup Lawsuits
The New Jersey Supreme Court has authorized the creation of a multicounty litigation (MCL) docket for personal injury claims alleging that Monsanto’s Roundup weed killer caused non-Hodgkin lymphoma and other health problems. The order assigns all current and future Roundup-related cases in the state to Judge Gregg A. Padovano in Bergen County for coordinated pretrial proceedings.
This decision follows a renewed request from plaintiffs in February 2025, citing 36 active cases across eight counties and anticipating that the case count would exceed 100. The court had previously denied MCL status in 2024 due to a lower number of filings. Plaintiffs argued that centralization would reduce redundant discovery and prevent inconsistent rulings. Monsanto opposed the motion again, asserting that the volume did not warrant consolidation.
While the decision to consolidate Roundup cases into a multicounty litigation docket isn’t a major event, it increases pressure on Bayer to pursue a global settlement or expedite the settlement process to reduce its inventory of lawsuits.
June 22, 2025 – U.S. Supreme Court to Consider Roundup Preemption Issue
The U.S. Supreme Court is scheduled to consider a petition for certiorari in Durnell v. Monsanto, a case with potentially significant implications for Roundup litigation nationwide. The central question is whether federal law—specifically the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)—preempts state-based failure-to-warn claims.
Monsanto argues that because the EPA has approved glyphosate-based product labels without cancer warnings, plaintiffs should not be able to sue under state law for failing to include such warnings. However, lower courts disagree. The Ninth Circuit has allowed these claims to proceed, while the Eleventh Circuit has ruled otherwise, creating a circuit split that the Supreme Court may now resolve.
The Court is expected to announce whether it will grant certiorari following its June 26, 2025, conference. If the Court takes the case, arguments would likely be heard during the 2025–2026 term.
This is a crucial point for plaintiffs and their attorneys. A ruling against Monsanto would affirm the ability of victims to hold the company accountable under state tort law, regardless of federal regulatory silence. A ruling in Monsanto’s favor could severely impact thousands of Roundup lawsuits pending across the country.
Regardless, the Supreme Court’s involvement highlights the high stakes and increases pressure on Bayer to seriously consider a global resolution before the legal landscape changes again. Nguyen Injury Lawyer is closely monitoring this case and will provide updates as they become available. If you or a loved one has been affected by Roundup exposure, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com to discuss your legal options. You can also reach us through our contact page at https://www.nguyeninjurylawyer.com/contact.
June 17, 2025 – New Study on Glyphosate
A significant new two-year study published in Environmental Health has found that glyphosate causes multiple types of cancer in rats, including leukemia, even at doses considered “safe” by regulators.
The study, conducted by Italy’s Ramazzini Institute with participation from institutions such as Boston College and Mount Sinai, exposed rats to glyphosate through drinking water beginning in the womb. Over 1,000 rats were monitored. All treated groups showed increased tumor rates compared to control groups, and many of the cancers were rare for this breed.
Key findings:
- Glyphosate and glyphosate-based herbicides both led to benign and malignant tumors.
- Leukemia was a primary concern, especially following prenatal exposure.
- The effects appeared even at doses below or equal to the current EU safety limits.
- Researchers suggest that the co-formulants in herbicide products may enhance glyphosate’s carcinogenic effects.
This study adds to the growing body of scientific evidence linking glyphosate exposure to cancer and other health issues, including liver, reproductive, and metabolic disorders.
June 16, 2025 – Settlement in Roundup Trial
Monsanto has reached a settlement in the Roundup cancer lawsuit brought by a Texas man, resolving the case just before closing arguments were scheduled to begin. The case, Grantges v. Monsanto, was being tried in St. Louis County Circuit Court.
This is a strategic move for Monsanto, which needs to avoid further significant verdicts.
June 13, 2025 – Punitive Damage Award Overturned by Florida Court
In a concerning decision, an intermediate appellate court has overturned punitive damages in a Roundup cancer case, depriving a California plaintiff of the $75 million awarded by the jury that heard the case. The plaintiff, who developed non-Hodgkin’s lymphoma after long-term use of Monsanto’s glyphosate-based herbicide, had convinced the jury that Monsanto acted with conscious disregard for human safety. However, the appellate court ruled that the punitive award was preempted by federal law, citing the EPA’s conclusion that glyphosate is “not likely” to be carcinogenic.
This ruling undermines the jury’s ability to punish corporate misconduct, even in the face of compelling internal evidence demonstrating that Monsanto knew about glyphosate’s cancer risks and intentionally chose not to warn the public.
The EPA’s regulatory opinion, which may change next year, should not be considered a free pass, especially given that the International Agency for Research on Cancer has classified glyphosate as a probable human carcinogen, and juries have repeatedly found Monsanto’s conduct reprehensible. Federal law sets a minimum standard, not a maximum. The jury considered Monsanto’s internal documents, which have consistently offended juries, ghostwritten studies, suppression of safety concerns, and manipulation of regulators, and made its decision accordingly.
June 6, 2025 – St. Louis County Trial
The Grantges v. Monsanto cancer trial is currently on Day 10 in St. Louis County Circuit Court. The plaintiff is still presenting his case against Monsanto Co., alleging that his non-Hodgkin’s lymphoma was caused by Roundup exposure. The plaintiffs called Donna Farmer and the plaintiff this week.
Donna Farmer is a Monsanto toxicologist and the company’s lead spokesperson on the safety of Roundup. She acknowledged in a 2009 internal email that “you cannot say that Roundup does not cause cancer,” admitting that Monsanto had not conducted carcinogenicity studies on the complete Roundup formulation. Dr. Farmer also admitted to editing scientific articles without being listed as an author and stated that it was standard practice for Monsanto to contribute content to publications authored by seemingly independent scientists.
May 27, 2025 – $611 Million Affirmed
In a significant victory for victims, a Missouri appellate court on May 27, 2025, affirmed a $611 million verdict against Monsanto, holding the company accountable for exposing consumers to Roundup, a product that juries are now repeatedly finding causes cancer. The original jury award totaled $1.56 billion but was reduced by the trial judge. Nevertheless, the appellate court’s decision maintains a substantial punitive award against Bayer’s Monsanto for knowingly selling a carcinogenic product without warning.
If you or a loved one has been diagnosed with non-Hodgkin’s lymphoma or another serious illness after exposure to Roundup, please contact Nguyen Injury Lawyer at XXX-XXX-XXXX for a free consultation. You can also visit our website at https://www.nguyeninjurylawyer.com or reach us through our contact page at https://www.nguyeninjurylawyer.com/contact to learn more about your legal rights and options.
Roundup Lawsuit Updates
The plaintiffs, all diagnosed with non-Hodgkin’s lymphoma, contended that Monsanto was aware of the risks associated with glyphosate, the active ingredient in Roundup, for many years but neglected to inform the public or remove the product from the market. The court dismissed Monsanto’s arguments that expert testimony concerning alleged EPA regulatory shortcomings was unfair (a critical point in this litigation) or that the damage awards were excessive.
May 19, 2025 – Bayer Considers Bankruptcy?
Bayer is reportedly considering filing for Chapter 11 bankruptcy for its Monsanto subsidiary. This action would transfer all current and future Roundup cancer lawsuits into bankruptcy court. According to a recent report in the Wall Street Journal, this strategy has gained traction within Bayer following repeated trial losses and over $10 billion already spent to settle claims linking Roundup to non-Hodgkin lymphoma.
There are two distinct interpretations of this situation. On one hand, it suggests Bayer cannot afford to fully compensate victims through settlements. In 2025, the company’s market capitalization has plummeted to approximately $25.65 billion, less than half the $63 billion it paid to acquire Monsanto in 2018.
Mathematically, $25.65 billion divided by 70,000 potential plaintiffs amounts to less than $400,000 per case—assuming every dollar of market value goes to claimants, which is unlikely. From Bayer’s perspective, pursuing a long-shot appeal to the U.S. Supreme Court might seem preferable to settling cases at such low figures. While this may be unwelcome news for plaintiffs, securing an average payout of even $100,000 per case in a global settlement may be challenging given the extent of the liabilities and Bayer’s financial difficulties, unless the goal is to bankrupt the company through litigation. Nguyen Injury Lawyer can help you understand your options.
Alternatively, Bayer’s actions may reflect a reluctance to pay rather than an inability to do so. Similar to Johnson & Johnson and 3M, Bayer appears to be employing a familiar corporate tactic—using the threat of bankruptcy to negotiate lower settlement amounts. However, unlike J&J’s “Texas Two-Step,” Bayer is not transferring its liabilities to a separate entity. This situation more closely resembles the Exactech litigation, where the company itself was driven into bankruptcy by the weight of the lawsuits. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact to discuss your case.
May 9, 2025 – Caranci Verdict Upheld
Monsanto’s attempt to overturn a $175 million verdict awarded to Ernest Caranci, an 83-year-old who developed non-Hodgkin’s lymphoma after decades of Roundup use, failed. The Philadelphia jury’s October 2023 verdict included $150 million in punitive damages. On May 8, 2025, the Pennsylvania Superior Court upheld the verdict, rejecting Monsanto’s appeal and confirming that the jury’s decision was supported by both scientific evidence and legal procedure. This decision affirms the significant verdict that initiated Phase II of the Bayer glyphosate litigation for plaintiffs, following a series of defense victories. Nguyen Injury Lawyer is closely monitoring these developments.
March 23, 2025 – $2.1 Billion Roundup Verdict Against Bayer in Georgia
A Georgia jury delivered a resounding message to Bayer, ordering the company to pay $2.1 billion to a plaintiff who developed non-Hodgkin lymphoma after using Roundup. The award included $65 million in compensatory damages and a staggering $2 billion in punitive damages—a clear condemnation of Bayer’s continued refusal to acknowledge the dangers of glyphosate. Our attorneys at Nguyen Injury Lawyer are experienced in handling these types of cases.
Bayer has reiterated its familiar argument that the verdict contradicts scientific evidence and regulatory consensus—a stance that is becoming increasingly untenable. The company will likely attempt to reduce the damages on appeal, as it has done in previous cases, where initial jury awards were reduced by 90% or more. However, the magnitude of this verdict highlights the ongoing risk Bayer faces by contesting these cases instead of settling them. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX to learn more.
This is the latest significant courtroom setback for Bayer, which is burdened by extensive Roundup litigation. Despite having paid $10 billion to settle previous claims, the company still faces over 60,000 active lawsuits, many of which are in state courts where juries have consistently ruled in favor of plaintiffs with substantial verdicts. Meanwhile, Bayer has allocated only $5.9 billion for future Roundup settlements—an amount that now appears woefully inadequate. The attorneys at Nguyen Injury Lawyer can evaluate your case.
This verdict also arrives at a crucial moment for Bayer, which is losing both in court and in public opinion. The company is actively lobbying Congress for immunity from Roundup lawsuits, warning lawmakers that it may withdraw the product from the U.S. market if litigation costs continue to rise. However, these empty threats are not deterring juries from penalizing Bayer for choosing to fight rather than fairly compensating victims. You can reach Nguyen Injury Lawyer through our website at https://www.nguyeninjurylawyer.com.
With another multi-billion-dollar verdict on the record, Bayer’s strategy appears increasingly imprudent. This case should serve as a stark warning: if the company continues to gamble with jury trials, it will only deepen its financial predicament.
March 19, 2025 – Push for Roundup Lawsuit Consolidation in New Jersey
A second request has been submitted to the New Jersey Supreme Court to centralize lawsuits against Monsanto and Bayer related to Roundup exposure. Plaintiffs in 36 cases across eight jurisdictions are seeking to consolidate their cases in Atlantic County Superior Court, arguing that centralization would enhance judicial efficiency, streamline discovery, and prevent inconsistent rulings. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX for a free consultation.
Currently, 41 cases are pending in New Jersey, with plaintiffs alleging that Roundup exposure has led to severe health conditions, including non-Hodgkin lymphoma. The plaintiffs anticipate that if their request is approved, the total number of cases could exceed 100. The New Jersey Supreme Court previously denied a similar request in June due to an insufficient number of cases. Monsanto has opposed the renewed bid, asserting that the number of claims does not warrant multicounty litigation.
December 8, 2024 – Mistrial Declared in Chicago
A mistrial was declared in a Chicago Roundup case after the defense inappropriately introduced an irrelevant and prejudicial reference to a past criminal charge against the plaintiff during cross-examination. The judge denounced the questioning as “serious misconduct” and cautioned the defense against further actions that could result in sanctions or contempt. Nguyen Injury Lawyer is committed to ensuring fair legal proceedings for our clients.
The plaintiffs filed a motion for mistrial following the defense’s blatant attempt to introduce an alcohol-related criminal charge involving the plaintiff, arguing that it was completely irrelevant to the case and served only to unfairly prejudice the jury. This type of evidence is so out of context that it becomes impossible to correct with a curative instruction. Monsanto’s lawyers should know better. Any law student who has taken an evidence class understands that such questioning is inadmissible.
November 20, 2024 – RFK Jr. and Roundup
Robert F. Kennedy Jr. has long been a vocal critic of Roundup. In 2018, he was involved with the legal team representing Dewayne Johnson, a former school groundskeeper who alleged that prolonged exposure to Roundup caused his non-Hodgkin’s lymphoma. Johnson’s case is widely considered the starting point for this litigation. A jury awarded Johnson $289 million, finding that Monsanto acted with “malice and oppression” by failing to warn consumers about the potential health risks of its product. The attorneys at Nguyen Injury Lawyer can help you understand your legal rights.
After the verdict, Kennedy remarked, “This jury found Monsanto acted with malice and oppression because they knew what they were doing was wrong and did it with reckless disregard for human life.” He called the decision a strong message to Monsanto’s boardroom. Whether one agrees with him or not, Kennedy’s stance on this issue is clear.
If Kennedy were to be confirmed as Secretary of Health and Human Services, his leadership could significantly influence the Roundup litigation. Consistent with his past advocacy, he would likely push for stricter oversight of herbicides and pesticides, potentially urging federal agencies like the EPA or FDA to re-evaluate the safety of glyphosate. Any regulatory action questioning or limiting glyphosate’s use could strengthen plaintiffs’ claims, supporting arguments that Roundup is hazardous and inadequately regulated. Nguyen Injury Lawyer can provide guidance on how regulatory changes may affect your case.
Such a shift in the regulatory and political landscape—particularly under a conservative administration—might compel Bayer to re-evaluate its current legal strategy and consider a more proactive approach towards a global Roundup settlement. Contact Nguyen Injury Lawyer at https://www.nguyeninjurylawyer.com/contact to discuss your case.
October 24, 2024 – Massachusetts State Court Follows 3rd Circuit
A Massachusetts state court has ruled that federal law preempts a plaintiff’s claims that Monsanto failed to warn about the potential dangers of its weed killer, Roundup. While claims related to design defects may still be viable, losing the failure-to-warn claim is undoubtedly a setback.
The ruling mirrors the 3rd Circuit’s opinion in Schaffner v. Monsanto. Nguyen Injury Lawyer is dedicated to protecting the rights of those harmed by Roundup.
The concern is that this case provides judges who are inclined to favor corporate protection, such as those who support Monsanto, with a legal basis to do so, and we will likely see more opinions like this.
October 10, 2024 – New $78 Million Verdict in Philadelphia
The jury in Melissen awarded $3 million in compensatory damages and $75 million in punitive damages. Plaintiffs needed a significant victory, and this was it. Nguyen Injury Lawyer is committed to fighting for justice for our clients.
September 11, 2024 – Loss in Philadelphia
In Young v. Monsanto, a Philadelphia jury found Monsanto not liable, rejecting claims that its Roundup weedkiller caused the plaintiff’s non-Hodgkin lymphoma. The jury determined that the plaintiff did not provide sufficient evidence to prove that Roundup caused his cancer. Our attorneys at Nguyen Injury Lawyer are here to assist you.
Plaintiffs will not prevail in every Roundup lawsuit. Some cases are stronger than others. However, to provide context, in the five Roundup cases tried in Philadelphia, plaintiffs have won three. The largest verdict was $2.25 billion (later reduced to $404 million), while the other two wins included verdicts of $3.5 million and $175 million. Including the two losses, the average of these verdicts is approximately $194.17 million.
August 16, 2024: Big Appellate Win for Bayer
Bayer secured a significant victory in the 3rd Circuit. The court ruled that federal pesticide labeling regulations preempt state laws. This decision, stemming from a case in Pennsylvania, revolves around whether EPA-approved pesticide labels, which do not include cancer warnings for Roundup, override state requirements for such warnings. Nguyen Injury Lawyer is closely monitoring these legal developments.
The court emphasized that once the EPA approves a label that omits specific health warnings, state laws demanding those warnings are preempted by federal law.
While Bayer’s hope of this reaching the U.S. Supreme Court may be unrealistic, there is now a split among federal appellate courts regarding the issue of federal preemption of state warning requirements on pesticides. Therefore, the possibility is more plausible today than it was before this opinion.
July 23, 2024: Important Appellate Win in Oregon
The plaintiff won a significant appeal of a jury verdict in Oregon. The plaintiff argued that the trial court erred by excluding testimony from his expert, Dr. Charles Benbrook, regarding EPA regulations. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX for a consultation.
Dr. Benbrook was prepared to explain the U.S. pesticide regulatory framework, including how the EPA reviews products under FIFRA, evaluates cancer risks, and issues labeling requirements. He would have highlighted how the EPA’s approach can differ from agencies like the International Agency for Research on Cancer (IARC), particularly regarding glyphosate’s carcinogenicity.
The Oregon appellate court ruled that excluding his testimony was an error, reversed the judgment, and ordered a new trial. Monsanto cross-appealed, arguing that FIFRA preempted the claims, but the court rejected that argument, as every other court has, finding that neither express nor implied preemption applied. Our attorneys at Nguyen Injury Lawyer can help you understand your legal options.
June 5, 2024 – Roundup Verdict Reduced to $400 Million
Roundup Litigation Updates
A judge in the Philadelphia Court of Common Pleas recently reduced the $2.25 billion verdict in the McKivision case from January to $400 million. While we at Nguyen Injury Lawyer believe the jury’s original verdict should be respected, $400 million remains a substantial award.
May 23, 2024 – Existential Threat
Bayer AG’s Chief Executive Officer, Bill Anderson, has characterized the ongoing wave of Roundup lawsuits as an “existential threat” to the company. Speaking at the Executives’ Club of Chicago, Anderson stressed the serious nature of the litigation, conceding that the glyphosate litigation imperils Bayer’s ability to survive and continue innovating for farmers.
Our attorneys at Nguyen Injury Lawyer have long maintained this perspective. Like Anderson, we also recognize that Monsanto produces many other valuable products and contributes to agricultural innovation. These two realities can coexist.
The “existential threat” stems not from an uncontrollable situation, but from Bayer’s reluctance to take necessary steps to resolve the litigation. While this will require accepting losses and substantial settlement payments, isn’t that preferable to bankruptcy? That is the path Bayer is currently on.
April 6, 2024 – Billion Dollar Verdict Reduced
A judge reduced the $1.56 billion jury verdict awarded in Missouri state court last November to three plaintiffs to $611 million. While Bayer may view this as a victory, a $611 million verdict is still a significant outcome for the plaintiffs.
April 2, 2024 – New Roundup Lawsuits
Nguyen Injury Lawyer recently received a call from a new client diagnosed with non-Hodgkin lymphoma (NHL) in 2024. This individual’s situation underscores how this litigation unfolds. There is a latency period between Roundup exposure and the development of NHL. It can take several years for the exposure to initiate cellular changes that eventually lead to NHL or other cancers.
Even if Bayer ceased selling Roundup today—as of March 19—new claims would continue to emerge for the next decade due to this latency period. This poses a challenge for Bayer. Discontinuing the product or adding a warning label would at least begin to limit future litigation.
February 1, 2024 – What Is at Stake for Bayer
Reuters offered a pertinent observation: “‘What all of Bayer’s strategies have in common is that they will take years, and none is guaranteed to succeed. It could be a year or more before the Supreme Court hears any case, and if Bayer hopes to win at the state level, it would need to do so separately in each state’s highest court after making its way through mid-level appellate courts.’ ‘It’s almost naturally a bet-the-company posture,’ said David Noll, a Rutgers Law School professor who studies mass torts. ‘The litigation is in this strange holding pattern where Bayer is confident that it will eventually win on the science and knock out the entire litigation, but in the meantime, it’s getting clobbered with verdicts.’”
Bayer appears willing to risk the company on appellate court decisions after seven years of litigation, marked by losses on appeal or being overlooked by the Supreme Court.
January 30, 2023 – $6.7 Billion in Roundup Verdicts
Here is an updated summary of Roundup verdicts:
2024
- McKivision, Pennsylvania, $2.25B
2023
- Jones, California, Defense Verdict
- Martel, Pennsylvania, $3.46M
- Anderson and Two Others, Missouri, $1.56B
- Dennis, California, $332M
- Caranci, Pennsylvania, $175M
- Durnell, Missouri, $1.25M
- McCostlin, Missouri, Defense Verdict
- Gordon, Missouri, Defense Verdict
2022
- Ferro, Missouri, Defense Verdict
- Alesi, Missouri, Defense Verdict
- Johnson, Oregon, Defense Verdict
- Shelton, Missouri, Defense Verdict
2021
- Stephens, California, Defense Verdict
- Clark, California, Defense Verdict
2019
- Hardeman, MDL-CA, $80.2M
- Pilliod, California, $2.05B
2018
- Johnson, California, $289.2M
The average payout for the last six Roundup lawsuits that proceeded to trial, including the defense verdict, is a staggering $617,387,142.86.
January 26, 2024 – McKivision Verdict
The verdict in McKivision was $2.25 billion, including $250 million in compensatory damages and $2 billion in punitive damages.
This jury was well-informed, with half of the 12 jurors holding college degrees, and two possessing master’s degrees. Plaintiffs’ arguments resonate with diverse juries. Suggesting Bayer’s legal team focus on educated jurors appears misguided.
Nguyen Injury Lawyer urges Bayer to update Roundup’s warning label and resume settling cases with firms representing a large number of plaintiffs. While past verdicts have not led to significant changes, this one could potentially shift the trajectory of the litigation.
January 11, 2024 – Monsanto’s “Cynical Diversion”
A recurring theme is Monsanto’s perceived reaction to unfavorable outcomes.
Judge James Crumlish III of the Philadelphia Court of Common Pleas concurred, strongly objecting to Monsanto’s attempt to have him removed from the case following a $175 million verdict, deeming it a transparent and manipulative tactic aimed at undermining the jury and the trial judge. He characterized Monsanto’s actions as a delaying tactic and a cynical diversion.
This is not an isolated incident. Monsanto has previously sought to disqualify judges in other cases, alleging bias, including a failed attempt to disqualify a California judge and accusations of favoritism against a Philadelphia judge after a $3.5 million verdict. This approach suggests a lack of good faith.
Why is this significant? A rational defendant in Monsanto’s position would prioritize settling these lawsuits. Such behavior raises questions about the company’s judgment in this litigation. Nguyen Injury Lawyer believes that the responsible parties need to take control and resolve this situation.
2023 Updates
Roundup Update December 6, 2023
Bayer suffered another loss. A Philadelphia jury ordered Bayer to pay nearly $3.5 million to a woman who alleged Roundup caused her cancer. The verdict, following a three-week trial and two days of deliberation, included $462,500 in compensatory damages and $3 million in punitive damages.
This marks Bayer’s fifth consecutive loss. Another trial is scheduled in Philadelphia next month, and we at Nguyen Injury Lawyer predict a verdict exceeding $3.5 million.
In 15 trials, juries have awarded victims nearly $4.5 billion, averaging $300 million per verdict. Multiplying this average by the estimated 40,000 remaining cases yields $12 trillion. (This is an oversimplification due to trials with multiple plaintiffs, but it illustrates the potential magnitude.)
Roundup Update November 20, 2023
A Missouri jury ordered Monsanto to pay over $1.5 billion in damages to three former Roundup users who claimed the product caused their non-Hodgkin’s lymphomas. This verdict significantly alters the litigation landscape.
The state court in Jefferson City, Missouri, awarded the plaintiffs a combined $61.1 million in actual damages and $500 million each in punitive damages.
The plaintiffs, Valorie Gunther from New York, Jimmy Draeger from Missouri, and Daniel Anderson from California, were all diagnosed with non-Hodgkin’s lymphoma. The jury found Monsanto liable for their injuries due to inadequate warnings about Roundup’s dangers.
These recent verdicts will likely increase Roundup settlement amounts. Bayer’s strategy of delaying settlement in hopes of a favorable outcome is proving detrimental. The situation is escalating into an existential threat for Bayer.
Another verdict is expected soon in Philadelphia in Martel v. Nouryon Chemicals. Bayer should settle that case immediately.
Roundup Update November 2, 2023
The Legal Intelligencer accurately reported that plaintiffs’ Roundup attorneys are intensifying pressure on Bayer to resolve lawsuits or remove Roundup from the market following substantial verdicts totaling over half a billion dollars.
The recent verdicts in Missouri, Pennsylvania, and California have changed the landscape, prompting plaintiffs’ lawyers to demand fair settlement offers and a clear warning on the product.
According to a Cornell professor, “What’s surprising is they didn’t settle these cases. If I were Monsanto, I would settle the best cases with the best lawyers, and bring to trial the worst cases with the worst trials. I’m guessing they thought that was their strategy, too. But they made a mistake.”
This strategy was previously successful for Monsanto, securing nine consecutive wins. However, Bayer’s reluctance to overpay and high settlement demands from plaintiffs hindered progress.
Bayer is reportedly considering bankruptcy, but our attorneys at Nguyen Injury Lawyer believe this is unlikely. The “Texas two-step” corporate maneuver, often used for liability restructuring, is also unlikely to succeed and would only incur further legal expenses.
We reiterate our recommendation: settle these cases, add a warning label to the product, and resume leadership in the agricultural sector.
Roundup Update October 31, 2023
$332 million in Dennis. The jury awarded $7 million in compensatory damages and $325 million in punitive damages. Following a significant verdict last week, three wins in a few weeks, totaling over $500 million, represent a complete shift.
Despite Bayer’s previous nine trial wins, which we attributed to carefully selecting weak cases, these recent verdicts demonstrate otherwise.
Like Caranci, Mr. Dennis’s case was typical. He used Roundup on his lawn and garden for 35 years and was diagnosed with non-Hodgkin’s lymphoma at age 51. These standard Roundup lawsuits are resulting in substantial verdicts.
It is time to consider whether Roundup poses an existential threat to Bayer. Reasonable settlement compensation could resolve these claims, but if the situation continues to escalate, the consequences are uncertain.
Roundup Update October 28, 2023
$175 million verdict in Caranci!!!!
Roundup Update October 25, 2023
Reports indicate that Bayer made no offer in the Roundup lawsuit that resulted in a $1.25 million verdict. Bayer appears to be taking only cases it is confident of winning to trial. Therefore, a plaintiff’s victory suggests Bayer miscalculated its chances.
🔍 Roundup Lawsuit at a Glance
- ⚖️ Settlements to Date: Nearly 100,000 cases resolved for over $11 billion.
- Bayer reported thousands of settlements with one law firm in August 2025.
If you or a loved one has been affected by Roundup exposure and diagnosed with non-Hodgkin’s lymphoma, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com. You can also reach out through our contact page: https://www.nguyeninjurylawyer.com/contact.
Roundup Settlement Updates and Lawsuit Information (February 2026)
Here’s a summary of the current status of Roundup litigation:
- Bayer Settlement Offer: In February 2026, Bayer proposed a $7.25 billion settlement to address existing and future Roundup cancer claims.
- Monsanto Settlement: Monsanto recently settled a case during a trial in St. Louis County.
- New Report: A new “Make America Healthy Again” report identifies Roundup as a potential risk to children.
- Active Lawsuits: As of February 2026, approximately 61,000 cases are still pending.
- Court Trends: Recent jury verdicts have resulted in awards of $175 million, $332 million, $2.25 billion, and $2.1 billion.
- Financial Pressure: Bayer is facing increasing financial pressure as more trials approach and has added $1.37 in reserves for settlements and verdicts. Jury awards in 2023 and 2024 have already exceeded $3 billion combined. There is no indication that jurors are growing more sympathetic to the defense.
- Bankruptcy Threat: Bayer has threatened bankruptcy, which may be a real possibility.
- Settlement Status: There is no definitive update on a global Roundup settlement. Opinions vary on whether a resolution is near.
- Filing Deadlines: State deadlines vary, and some victims may have already missed the deadline to file. However, some individuals may incorrectly believe they are outside the filing window.
- Future Expectations: Bayer is actively negotiating behind the scenes while also hoping for intervention from the Supreme Court.
The Status of Pending Roundup Cases
In March 2022, Bayer, the owner of Roundup and Monsanto, informed investors that they had reached tentative settlement agreements in approximately 98,000 pending Roundup lawsuits. This represented nearly 80% of all open Roundup cases at the time. These settlements were primarily achieved through block settlement arrangements with attorneys handling large volumes of cases. As of 2025, roughly 61,000 Roundup lawsuits remain active following a series of settlements in August 2025.
Understanding the Roundup Settlement Points System
Roundup settlements utilize a complex point-scoring system to categorize cases into settlement tiers based on the strength of the claims and the severity of the injuries. Factors such as the type of cancer, treatment outcomes, the victim’s age, and estimated earning capacity are assigned point values. Individual cases are then placed into settlement tiers based on their total points, with higher scores resulting in larger payouts and lower scores leading to smaller payouts.
Analyzing the $7.25 Billion Settlement Offer
In February 2026, Bayer announced a proposed $7.25 billion settlement aimed at resolving both current and future Roundup cancer claims. While this figure may seem substantial, the details are critical. The settlement requires near-universal participation, and Bayer retains the right to withdraw the offer if too many plaintiffs choose to opt out. This condition provides Bayer with significant leverage and creates uncertainty for victims. The company’s decision to proceed with the deal will depend on the number of opt-outs and the Supreme Court’s stance on any appeals.
On a positive note, the settlement encompasses future claims from individuals who may develop non-Hodgkin lymphoma in the years to come. However, this also means that the settlement fund must be distributed among an unknown number of future claimants.
If you have a pending Roundup claim, you will likely have the option to participate in this settlement or opt out and pursue your own lawsuit. The opt-out deadline is June 4, 2026. Opting out preserves your right to go to trial but also exposes you to the risk that Bayer’s Supreme Court appeal could alter the legal landscape. Many attorneys are now advising their clients to accept the settlement offer.
Frequently Asked Questions About Roundup Lawsuits in 2026
How many Roundup lawsuits have been filed and settled to date?
As of winter 2026, Monsanto has settled nearly 100,000 Roundup lawsuits, representing the majority of the original claims filed. These settlements were part of Bayer’s $11 billion effort to resolve the bulk of the litigation after acquiring Monsanto.
However, approximately 61,000 active Roundup lawsuits remain pending nationwide, primarily in state courts, although over 4,000 are still part of the federal multidistrict litigation (MDL) in California. New lawsuits continue to be filed weekly, particularly by individuals recently diagnosed with non-Hodgkin’s lymphoma, indicating that the litigation is ongoing.
What is the average payout for a Roundup lawsuit?
In the initial settlement program, payouts typically ranged from $100,000 to $160,000. This occurred during the first wave of claims when Bayer was attempting to mitigate the damage and avoid further courtroom losses.
Currently, we are in what is often referred to as “Roundup Phase 2,” where there was hope for increased payouts due to several significant jury verdicts between 2023 and 2025. Juries have awarded $175 million, $332 million, $2.25 billion, and even $2.1 billion in individual and consolidated cases, reflecting the risk Bayer faces by continuing to litigate these cases.
However, higher average payouts in this next round of settlements are unlikely. It is not anticipated that settlements will exceed those of the first round, primarily due to Bayer’s financial constraints. Despite some improvement, the company’s financial health remains a concern, with a significantly lower valuation compared to the first round of settlements. A company with a $26 billion valuation cannot afford to pay $26 billion in settlements.
Why are Roundup lawsuits still being filed in 2026?
Roundup lawsuits continue to be filed because many individuals who used Roundup in the past are only now being diagnosed with non-Hodgkin lymphoma. The latency period between exposure and the development of symptoms means that new cases may continue to emerge for years. Additionally, the product remains available on the market.
Increased awareness also plays a role. The significant jury verdicts have raised public awareness, prompting individuals to recognize the potential link between Roundup and their cancer. Once they make this connection, they seek legal assistance. If you or a loved one has been recently diagnosed and used Roundup, it is crucial to act quickly as the filing window may be closing.
Is there still time to file a Roundup lawsuit?
Yes, there may still be time to file a lawsuit, but it depends on your location and the date of your diagnosis. Each state has its own statute of limitations, with some providing two or three years from the date of diagnosis, while others follow different rules.
It is crucial to understand that timing is critical. A recent case in Philadelphia was dismissed due to the statute of limitations, despite the strong evidence supporting the plaintiff’s claim. If you believe Roundup may have contributed to your diagnosis, it is essential to consult with an attorney as soon as possible.
How do Roundup settlement tiers work, and what does that mean for payout amounts?
The Roundup settlement program does not offer a uniform payout. When Bayer initially agreed to settle a large group of lawsuits in 2020, they established a point-based system to determine the compensation each plaintiff would receive. This structure is likely to influence the next round of settlements in 2026 and beyond.
Each case is evaluated using a scoring system that assigns points based on various factors, including the type and stage of cancer, the plaintiff’s age, the duration and frequency of Roundup use, the impact of the disease on their ability to work, the intensity of treatment, and whether the person has passed away. Some cases may also receive “bonus” points for particularly strong causal links or compelling stories.
These points are then used to categorize cases into settlement tiers, with higher-tier cases receiving more compensation and lower-tier cases qualifying for smaller payouts. For example, someone with aggressive, late-stage NHL and long-term Roundup use who is under 50 might receive significantly more than a claimant with earlier-stage disease and more limited exposure.
If you have a claim or are considering filing one, it is important to understand that your case will be evaluated based on its own merits. While the high-profile verdicts in court send a message, individual settlements still heavily depend on the specific facts of each case.
For guidance from a Roundup attorney to fight against Monsanto, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or through our website’s contact page at https://www.nguyeninjurylawyer.com/contact.